Greenwich LifeSciences, Inc.
GLSI
$11.67
-$0.26-2.18%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -4.03M | -3.26M | -8.04M | -2.67M | -2.61M |
Total Depreciation and Amortization | 900.00 | 900.00 | 900.00 | 900.00 | 900.00 |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.54M | 1.54M | 5.47M | 594.50K | 594.50K |
Change in Net Operating Assets | 247.10K | -121.20K | 717.30K | -510.60K | 963.40K |
Cash from Operations | -2.23M | -1.83M | -1.85M | -2.58M | -1.05M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 2.61M | 492.40K | 121.80K | 1.18M | 2.77M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 2.61M | 492.40K | 121.80K | 1.18M | 2.77M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 375.10K | -1.34M | -1.73M | -1.40M | 1.72M |